Cancer drug effective fertility treatment

US researchers randomly assigned 750 infertile women aged 18—40 diagnosed using the Rotterdam criteria to receive up to five cycles of either clomiphene or letrozole, an aromatase inhibitor for the treatment of hormone-dependent breast cancer in postmenopausal women.